UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2021
Commission File Number 001-40635
Field Trip Health Ltd.
(Exact name of Registrant as specified in its charter)
N/A
(Translation of Registrant’s name)
30 Duncan Street, Suite 401
Toronto, ON, Canada M5V 2C3
1-833-222-0084
(Address and telephone number of registrant’s principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ¨ Form 40-F x
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
DOCUMENTS INCLUDED AS PART OF THIS REPORT
| Exhibit | ||
| 99.1 | News Release, dated September 24, 2021 | |
| 99.2 | Material Change Report, dated September 27, 2021 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Field Trip Health Ltd. | |||
| Date: September 28, 2021 | By: | /s/ Donna Wong | |
| Name: | Donna Wong | ||
| Title: | Chief Financial Officer | ||